Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 6
2021 4
2022 2
2023 4
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis.
Le Turnier P, Gregoire M, Deslandes G, Lakhal K, Deschanvres C, Lecomte R, Talarmin JP, Dubée V, Bellouard R, Boutoille D, Leroy AG, Gaborit BJ; NAMAP study group. Le Turnier P, et al. Among authors: gaborit bj. Clin Microbiol Infect. 2020 Oct;26(10):1415.e1-1415.e4. doi: 10.1016/j.cmi.2020.04.046. Epub 2020 May 8. Clin Microbiol Infect. 2020. PMID: 32437956 Free article.
Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
Lécuyer R, Issa N, Camou F, Lavergne RA, Gabriel F, Morio F, Canet E, Raffi F, Boutoille D, Cady A, Gousseff M, Crabol Y, Néel A, Tessoulin B, Gaborit B; PRONOCYSTIS Study Group. Lécuyer R, et al. Chest. 2024 Jun;165(6):1319-1329. doi: 10.1016/j.chest.2024.01.015. Epub 2024 Jan 11. Chest. 2024. PMID: 38215935 Free article.
Lopinavir pharmacokinetics in COVID-19 patients.
Gregoire M, Le Turnier P, Gaborit BJ, Veyrac G, Lecomte R, Boutoille D, Canet E, Imbert BM, Bellouard R, Raffi F. Gregoire M, et al. Among authors: gaborit bj. J Antimicrob Chemother. 2020 Sep 1;75(9):2702-2704. doi: 10.1093/jac/dkaa195. J Antimicrob Chemother. 2020. PMID: 32443151 Free PMC article. No abstract available.
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Hervochon C, Hennart B, Leroy AG, Corvec S, Boutoille D, Senneville É, Sotto A, Illes G, Chavanet P, Dubée V, Bleibtreu A, De Carné MC, Talarmin JP, Revest M, Castan B, Bellouard R, Dailly É, Allorge D, Dinh A, Le Turnier P, Gregoire M; Dalbavancin Pharmacokinetics (DALBAP) study group. Hervochon C, et al. J Antimicrob Chemother. 2023 Dec 1;78(12):2919-2925. doi: 10.1093/jac/dkad331. J Antimicrob Chemother. 2023. PMID: 37864551
Plea for multitargeted interventions for severe COVID-19.
Gaborit BJ, Bergmann JF, Mussini C, Arribas JR, Behrens G, Walmsley S, Pozniak A, Raffi F. Gaborit BJ, et al. Lancet Infect Dis. 2020 Oct;20(10):1122-1123. doi: 10.1016/S1473-3099(20)30312-1. Epub 2020 Apr 21. Lancet Infect Dis. 2020. PMID: 32325035 Free PMC article. No abstract available.
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
Lécuyer R, Issa N, Tessoulin B, Lavergne RA, Morio F, Gabriel F, Canet E, Bressollette-Bodin C, Guillouzouic A, Boutoille D, Raffi F, Lecomte R, Le Turnier P, Deschanvres C, Camou F, Gaborit BJ; PRONOCYSTIS Study Group. Lécuyer R, et al. Among authors: gaborit bj. J Infect Dis. 2022 Mar 2;225(5):868-880. doi: 10.1093/infdis/jiab460. J Infect Dis. 2022. PMID: 34604908
Development and validation of a dosing nomogram for amoxicillin in infective endocarditis.
Rambaud A, Gaborit BJ, Deschanvres C, Le Turnier P, Lecomte R, Asseray-Madani N, Leroy AG, Deslandes G, Dailly É, Jolliet P, Boutoille D, Bellouard R, Gregoire M; Nantes Anti-Microbial Agents PK/PD (NAMAP) study group. Rambaud A, et al. Among authors: gaborit bj. J Antimicrob Chemother. 2020 Oct 1;75(10):2941-2950. doi: 10.1093/jac/dkaa232. J Antimicrob Chemother. 2020. PMID: 32601687
Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
Gaborit B, Lécuyer R, Issa N, Camou F, Lavergne RA, Gabriel F, Morio F, Canet E, Raffi F, Boutoille D, Cady A, Gousseff M, Crabol Y, Néel A, Tessoulin B; Prognostic Factors in Pneumocystis Pneumoniae (PRONOCYSTIS) Study Group. Gaborit B, et al. Chest. 2024 Oct;166(4):708-711. doi: 10.1016/j.chest.2024.04.038. Epub 2024 Jun 10. Chest. 2024. PMID: 38866071 Free article. No abstract available.
24 results